Truncation mutations abolish chromatin-associated activities of adenomatous polyposis coli

Oncogene

Volumn 27, Issue 36, 2008, Pages 4888-4899

  Kouzmenko, A P ^a,b   Takeyama, K ^a   Kawasaki, Y ^a   Akiyama, T ^a   Kato, S ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Adenomatous polyposis coli; Chromatin; DNA repair; Nuclear protein complexes

Indexed keywords

DNA DEPENDENT PROTEIN KINASE; DOUBLE STRANDED DNA; HISTONE H2AX; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CELL MUTANT; CHROMATIN; COLON POLYPOSIS; COLORECTAL TUMOR; DNA REPAIR; ENZYME ACTIVE SITE; EUCHROMATIN; HUMAN; HUMAN CELL; IN VIVO STUDY; MUTATION; PHOSPHORYLATION; PRIORITY JOURNAL;

ADENOMATOUS POLYPOSIS COLI; BINDING SITES; CELL LINE; CHROMATIN; DNA DAMAGE; DNA REPAIR; GENES, APC; HISTONE ACETYLTRANSFERASES; HUMANS; MUTATION; TRANS-ACTIVATION (GENETICS);

EID: 48949112430     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.127     Document Type: Article

References (65)

1. Akiyama T, Kawasaki Y. (2006). Wnt signalling and the actin cytoskeleton. Oncogene 25:7538-7544.
2. Bassing CH, Suh H, Ferguson DO, Chua KF, Manis J, Eckersdorff M et al. (2003). Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114:359-370.
3. Bienz M. (2002). The subcellular destinations of APC proteins. Nat Rev Mol Cell Biol 3:328-338.
4. Brocardo M, Nathke IS, Henderson BR. (2005). Redefining the subcellular location and transport of APC: new insights using a panel of antibodies. EMBO Rep 6:184-190.
5. Burma S, Chen DJ. (2004). Role of DNA-PK in the cellular response to DNA double-strand breaks. DNA Repair (Amst) 3:909-918.
6. Celeste A, Difilippantonio S, Difilippantonio MJ, Fernandez-Capetillo O, Pilch DR, Sedelnikova OA et al. (2003). H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 114:371-383.
7. Deka J, Herter P, Sprenger-Haussels M, Koosch S, Franz D, Muller KM et al. (1999). The APC protein binds to A/T rich DNA sequences. Oncogene 18:5654-5661.
8. Dempke W, Voigt W, Grothey A, Hill BT, Schmoll HJ. (2000). Cisplatin resistance and oncogenes - a review. Anticancer Drugs 11:225-236.
9. Fagman H, Larsson F, Arvidsson Y, Meuller J, Nordling M, Martinsson T et al. (2003). Nuclear accumulation of full-length and truncated adenomatous polyposis coli protein in tumor cells depends on proliferation. Oncogene 22:6013-6022.
10. Faux MC, Ross JL, Meeker C, Johns T, Ji H, Simpson RJ et al. (2004). Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. J Cell Sci 117:427-439.
11. Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A. (2004). H2AX: the histone guardian of the genome. DNA Repair (Amst) 3:959-967.
12. Fodde R, Smits R, Clevers H. (2001). APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1:55-67.
13. Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA. (2003). MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113:207-219.
14. Furuta T, Takemura H, Liao ZY, Aune GJ, Redon C, Sedelnikova OA et al. (2003). Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J Biol Chem 278:20303-20312.
15. Gaasenbeek M, Howarth K, Rowan AJ, Gorman PA, Jones A, Chaplin T et al. (2006). Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers. Cancer Res 66:3471-3479.
16. Gounari F, Chang R, Cowan J, Guo Z, Dose M, Gounaris E et al. (2005). Loss of adenomatous polyposis coli gene function disrupts thymic development. Nat Immunol 6:800-809.
17. Green RA, Kaplan KB. (2003). Chromosome instability in colorectal tumor cells is associated with defects in microtubule plus-end attachments caused by a dominant mutation in APC. J Cell Biol 163:949-961.
18. Groisman R, Polanowska J, Kuraoka I, Sawada J, Saijo M, Drapkin R et al. (2003). The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 113:357-367.
19. Henderson BR. (2000). Nuclear-cytoplasmic shuttling of APC regulates β-catenin subcellular localization and turnover. Nat Cell Biol 2:653-660.
20. Henderson BR, Fagotto F. (2002). The ins and outs of APC and β-catenin nuclear transport. EMBO Rep 3:834-839.
21. Hermsen M, Postma C, Baak J, Weiss M, Rapallo A, Sciutto A et al. (2002). Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 123:1109-1119.
22. Homfray TF, Cottrell SE, Ilyas M, Rowan A, Talbot IC, Bodmer WF et al. (1998). Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours. Hum Mutat 11:114-120.
23. Ishiguro K, Yoshida T, Yagishita H, Numata Y, Okayasu T. (2006). Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas. Gut 55:695-702.
24. Jimbo T, Kawasaki Y, Koyama R, Sato R, Takada S, Haraguchi K et al. (2002). Identification of a link between the tumour suppressor APC and the kinesin superfamily. Nat Cell Biol 4:323-327.
25. Joslyn G, Richardson DS, White R, Alber T. (1993). Dimer formation by an N-terminal coiled coil in the APC protein. Proc Natl Acad Sci USA 90:11109-11113.
26. Ju BG, Lunyak VV, Perissi V, Garcia-Bassets I, Rose DW, Glass CK et al. (2006). A topoisomerase IIβ-mediated dsDNA break required for regulated transcription. Science 312:1798-1802.
27. Kawasaki Y, Senda T, Ishidate T, Koyama R, Morishita T, Iwayama Y et al. (2000). Asef, a link between the tumor suppressor APC and G-protein signaling. Science 289:1194-1197.
28. Kawasaki Y, Sagara M, Shibata Y, Shirouzu M, Yokoyama S, Akiyama T. (2007). Identification and characterization of Asef2, a guanine-nucleotide exchange factor specific for Rac1 and Cdc42. Oncogene 26:7620-7627.
29. Kawasaki Y, Sato R, Akiyama T. (2003). Mutated APC and Asef are involved in the migration of colorectal tumour cells. Nat Cell Biol 5:211-215.
30. Khanna KK, Jackson SP. (2001). DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27:247-254.
31. Kinzler KW, Vogelstein B. (1996). Lessons from hereditary colorectal cancer. Cell 87:159-170.
32. Kitagawa H, Fujiki R, Yoshimura K, Mezaki Y, Uematsu Y, Matsui D et al. (2003). The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 113:905-917.
33. Kouzmenko AP, Takeyama K, Ito S, Furutani T, Sawatsubashi S, Maki A et al. (2004). Wnt/β-catenin and estrogen signaling converge in vivo. J Biol Chem 279:40255-40258.
34. Kouzmenko AP, Takeyama K, Kawasaki Y, Akiyama T, Kato S. (2008). Ligand-dependent interaction between estrogen receptor α and adenomatous polyposis coli. Genes Cells (in press).
35. Lee KK, Workman JL. (2007). Histone acetyltransferase complexes: one size doesn't fit all. Nat Rev Mol Cell Biol 8:284-295.
36. Li Z, Nathke IS. (2005). Tumor-associated NH2-terminal fragments are the most stable part of the adenomatous polyposis coli protein and can be regulated by interactions with COOH-terminal domains. Cancer Res 65:5195-52 04.
37. Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL et al. (2001). Siah-1 mediates a novel β-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 7:927-936.
38. Memezawa A, Takada I, Takeyama K, Igarashi M, Ito S, Aiba S et al. (2007). Id2 gene-targeted crosstalk between Wnt and retinoid signaling regulates proliferation in human keratinocytes. Oncogene 26:5038-5045.
39. Mogensen MM, Tucker JB, Mackie JB, Prescott AR, Nathke IS. (2002). The adenomatous polyposis coli protein unambiguously localizes to microtubule plus ends and is involved in establishing parallel arrays of microtubule bundles in highly polarized epithelial cells. J Cell Biol 157:1041-1048.
40. Morrison AJ, Shen X. (2005). DNA repair in the context of chromatin. Cell Cycle 4:568-571.
41. Murr R, Vaissiere T, Sawan C, Shukla V, Herceg Z. (2007). Orchestration of chromatin-based processes:mind the TRRAP. Oncogene 26:5358-5372.
42. Nathke I. (2006). Cytoskeleton out of the cupboard:colon cancer and cytoskeletal changes induced by loss of APC. Nat Rev Cancer 6:967-974.
43. Nathke IS. (2004). The adenomatous polyposis coli protein:th e Achilles heel of the gut epithelium. Annu Rev Cell Dev Biol 20:337-366.
44. Neufeld KL, Zhang F, Cullen BR, White RL. (2000). APC-mediated downregulation of b-catenin activity involves nuclear sequestration and nuclear export. EMBO Rep 1:519-523.
45. Ohtake F, Baba A, Takada I, Okada M, Iwasaki K, Miki H et al. (2007). Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 446:562-566.
46. Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K et al. (2003). Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423:545-550.
47. Osley MA, Shen X. (2006). Altering nucleosomes during DNA double-strand break repair in yeast. Trends Genet 22:671-677.
48. Park JH, Park EJ, Lee HS, Kim SJ, Hur SK, Imbalzano AN et al. (2006). Mammalian SWI/SNF complexes facilitate DNA double-strand break repair by promoting gamma-H2AX induction. EMBO J 25:3986-3997.
49. Pommier Y. (2006). Topoisomerase I inhibitors:camptothec ins and beyond. Nat Rev Cancer 6:789-802.
50. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN et al. (1992). APC mutations occur early during colorectal tumorigenesis. Nature 359:235-237.
51. Rosin-Arbesfeld R, Townsley F, Bienz M. (2000). The APC tumour suppressor has a nuclear export function. Nature 406:1009-1012.
52. Schneikert J, Grohmann A, Behrens J. (2007). Truncated APC regulates the transcriptional activity of β-catenin in a cell cycle dependent manner. Hum Mol Genet 16:199-209.
53. Shibata H, Toyama K, Shioya H, Ito M, Hirota M, Hasegawa S et al. (1997). Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278:120-123.
54. Shih IM, Zhou W, Goodman SN, Lengauer C, Kinzler KW, Vogelstein B. (2001). Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 61:818-822.
55. Sierra J, Yoshida T, Joazeiro CA, Jones KA. (2006). The APC tumor suppressor counteracts β-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev 20:586-600.
56. Squatrito M, Gorrini C, Amati B. (2006). Tip60 in DNA damage response and growth control: many tricks in one HAT. Trends Cell Biol 16:433-442.
57. Steffensen IL, Schut HA, Alexander J. (2005). Age at exposure and Apc status influence the levels of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in mouse intestine and liver. Mutat Res 587:73-89.
58. Steffensen IL, Schut HA, Nesland JM, Tanaka K, Alexander J. (2006). Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice. Mutat Res 611:71-82.
59. Strom A, Bonal C, Ashery-Padan R, Hashimoto N, Campos ML, Trumpp A et al. (2007). Unique mechanisms of growth regulation and tumor suppression upon Apc inactivation in the pancreas. Development 134:2719-2725.
60. Tighe A, Johnson VL, Taylor SS. (2004). Truncating APC mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability. J Cell Sci 117:6339-6353.
61. van Attikum H, Gasser SM. (2005). The histone code at DNA breaks: a guide to repair? Nat Rev Mol Cell Biol 6:757-765.
62. Wysocka J, Swigut T, Xiao H, Milne TA, Kwon SY, Landry J et al. (2006). A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodeling. Nature 442:86-90.
63. Xiao JH, Ghosn C, Hinchman C, Forbes C, Wang J, Snider N et al. (2003). Adenomatous polyposis coli (APC)-independent regulation of β-catenin degradation via a retinoid X receptor-mediated pathway. J Biol Chem 278:29954-2 9962.
64. Yanagisawa J, Kitagawa H, Yanagida M, Wada O, Ogawa S, Nakagomi M et al. (2002). Nuclear receptor function requires a TFTC-type histone acetyl transferase complex. Mol Cell 9:553-562.
65. Zhang F, White RL, Neufeld KL. (2001). Cell density and phosphorylation control the subcellular localization of adenomatous polyposis coli protein. Mol Cell Biol 21:8143-8156.